Ioflupane (123I)
Tier C — Watch / tradeIoflupane (123I)
Targets:Not applicable
Brand:DaTSCAN, Striascan
Indications (approved):Lewy body dementia, Diagnostic agent, Parkinsonism, Alzheimer's disease, Parkinson's disease
Regional status
Synthetic routes & intermediates3 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| Ioflupane (123I)-001 | - | Methyl(2S,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-002 | - | Methyl(2S,3S)-3-(4-iodophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-003 | 352-91-0 | 1-Bromo-3-fluoropropane |
| Ioflupane (123I)-004 | - | Methyl(2S,3S)-8-(3-fluoropropyl)-3-(4-iodophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-005 | 155798-00-8 | Methyl(1R,2S,3S,5S)-8-(3-fluoropropyl)-3-[4-(trimethylstannyl)phenyl]-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Code | CAS No. | Intermediate |
|---|---|---|
| Ioflupane (123I)-006 | 532-24-1 | 8-Methyl-8-azabicyclo[3.2.1]octan-3-one |
| Ioflupane (123I)-007 | 616-38-6 | Carbonicaciddimethyldiester |
| Ioflupane (123I)-008 | 67-56-1Available | Hydroxymethane |
| Ioflupane (123I)-009 | 36127-17-0 | Methyl8-methyl-3-oxo-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-010 | 106293-60-1 | Methyl3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-011 | 127379-24-2 | Methyl8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate |
| Ioflupane (123I)-012 | 106-37-6Available | 1,4-Dibromobenzene |
| Ioflupane (123I)-013 | 135367-08-7 | (±)-Methyl(1R*,2S*,3S*,5S*)-3-(4-bromophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-014 | 189950-17-2 | (±)-Methyl(1R*,2S*,3S*,5S*)-3-(4-bromophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-003 | 352-91-0 | 1-Bromo-3-fluoropropane |
| Ioflupane (123I)-015 | 343312-15-2 | Methyl(1R,2S,3S,5S)-3-(4-bromophenyl)-8-(3-fluoropropyl)-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-005 | 155798-00-8 | Methyl(1R,2S,3S,5S)-8-(3-fluoropropyl)-3-[4-(trimethylstannyl)phenyl]-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Code | CAS No. | Intermediate |
|---|---|---|
| Ioflupane (123I)-016 | 1933755-75-9 | Methyl(2R,3S)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-017 | - | Methyl(2R,3S)-3-(benzyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-011 | 127379-24-2 | Methyl8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate |
| Ioflupane (123I)-018 | 100-58-3 | Bromo(phenyl)magnesium |
| Ioflupane (123I)-019 | - | Methyl(2S,3S)-8-methyl-3-phenyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-001 | - | Methyl(2S,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-020 | - | Methyl(2S,3S)-8-methyl-3-[4-(tributylstannyl)phenyl]-8-azabicyclo[3.2.1]octane-2-carboxylate |
| Ioflupane (123I)-021 | - | Methyl(2S,3S)-3-[4-[123I]iodophenyl]-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
Frequently asked questions
What are the approved indications of Ioflupane (123I)?
Approved indications include: Lewy body dementia, Diagnostic agent, Parkinsonism, Alzheimer's disease, Parkinson's disease.
When does the Ioflupane (123I) patent expire?
No public expiry year is available for Ioflupane (123I) yet; this page updates once verified.
How many synthesis routes are recorded for Ioflupane (123I)?
3 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Ioflupane (123I) intermediates?
2 intermediate CAS of Ioflupane (123I) are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Ioflupane (123I) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29